Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for WBC's Women's Capital Summit
May 21-22, 2025 • New York
The WBC Women’s Capital Summit aims to provide valuable insights into the world of capital, offering a deep understanding of its dynamics, strategic relevance at different stages of a company’s growth, and the effective utilization of capital resources.
Trina Spear is the CEO and Co-Founder of FIGS, the digitally native, DTC healthcare apparel and lifestyle brand creating technically advanced products for the modern healthcare professional. Under Trina’s leadership,
Trina Spear is the CEO and Co-Founder of FIGS, the digitally native, DTC healthcare apparel and lifestyle brand creating technically advanced products for the modern healthcare professional. Under Trina’s leadership,
Dr. Catherine Corrigan is President and CEO of Exponent. She joined the company in 1996, was promoted to principal in the Biomechanics Practice in 2002, and to corporate vice president
Dr. Catherine Corrigan is President and CEO of Exponent. She joined the company in 1996, was promoted to principal in the Biomechanics Practice in 2002, and to corporate vice president
Catherine J. Boggs is the CEO of Hecla Mining Company, one of the largest silver mining companies in North America. Boggss leadership is characterized by a focus on operational excellence,
Catherine J. Boggs is the CEO of Hecla Mining Company, one of the largest silver mining companies in North America. Boggss leadership is characterized by a focus on operational excellence,
Cathy O’Callaghan is the CEO of Ford Motor Company, a global automotive leader renowned for its innovation and commitment to quality. O’Callaghans leadership is defined by a focus on technological
Cathy O’Callaghan is the CEO of Ford Motor Company, a global automotive leader renowned for its innovation and commitment to quality. O’Callaghans leadership is defined by a focus on technological
Carrie Eglinton Manner serves as President, Chief Executive Officer & Director of OraSure Technologies, Inc. since 2022. She serves as an Independent Director of Repligen Corporation since June 11, 2020.
Carrie Eglinton Manner serves as President, Chief Executive Officer & Director of OraSure Technologies, Inc. since 2022. She serves as an Independent Director of Repligen Corporation since June 11, 2020.
Caryn Seidman-Becker is the co-founder and CEO of CLEAR, the secure identity platform, which uses biometrics to make proving you are you simple. A former hedge fund manager, she and
Caryn Seidman-Becker is the co-founder and CEO of CLEAR, the secure identity platform, which uses biometrics to make proving you are you simple. A former hedge fund manager, she and
Carey Smith has served as President of Parsons since November 2019 and as CEO since July 2021. In these capacities, she is responsible for strategy, growth and execution at Parsons,
Carey Smith has served as President of Parsons since November 2019 and as CEO since July 2021. In these capacities, she is responsible for strategy, growth and execution at Parsons,
Carla Vernon is the CEO of The Honest Company, Inc., a renowned consumer goods company known for its commitment to natural, safe, and effective products. Vernons leadership is marked by
Carla Vernon is the CEO of The Honest Company, Inc., a renowned consumer goods company known for its commitment to natural, safe, and effective products. Vernons leadership is marked by
Carol B. Tomé is the Chief Executive Officer of UPS. She is the 12th CEO in the 116-year history of the company. Before joining UPS, Carol served as Executive Vice
Carol B. Tomé is the Chief Executive Officer of UPS. She is the 12th CEO in the 116-year history of the company. Before joining UPS, Carol served as Executive Vice
Carole S. Ben-Maimon, M.D., is the CEO of Larimar Therapeutics, Inc., a biotechnology company dedicated to developing treatments for rare and serious diseases. Dr. Ben-Maimons leadership is characterized by a
Carole S. Ben-Maimon, M.D., is the CEO of Larimar Therapeutics, Inc., a biotechnology company dedicated to developing treatments for rare and serious diseases. Dr. Ben-Maimons leadership is characterized by a
